Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Focus II: Exablate MRgFUS Subthalamotomy in Early-Stage Parkinson's Disease
NCT06584383Active, not recruiting
- Sponsor
- Insightec
- Start
- Aug 2024
- Primary completion
- Sep 2027
- Countries
- 3
01
Overview
Randomised, open-label trial in Parkinson's disease (PD) (3 arms), sponsored by Insightec. Primary endpoint: MDS-UPDRS Part III OFF Medication at 12 Months. Started Aug 2024; status: active, not recruiting.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06584383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06584383.